Investment Firm
Overview
Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.
Mar 23, 2023
Post Ipo Equity
Highlights
N/A
Location
Social
N/A
Investor Lead
Participant Investors
1
Investor Name |
---|
Moderna |
Generation Bio raised $76000000 on 2023-03-23 in Post-IPO Equity
Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.
Company Funding History
5
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Feb 27, 2018 | Series B - Generation Bio | 6 | - | 100.0M |
Jan 10, 2020 | Series C - Generation Bio | 9 | - | 110.0M |
Jan 06, 2021 | Post-IPO Equity - Generation Bio | - | 225.4M | |
Mar 23, 2023 | Post-IPO Equity - Generation Bio | 1 | - | 76.0M |
Recent Activity
There is no recent news or activity for this profile.